APTA.L
Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The company's binders engineered to address issues which founds with molecules, such as antibodies; and offers solutions to bioprocessing, diagnostic, and pharmaceutical scientists. It serves pharma companies, diagnostic development companies, and research institutes. The company was incorporated in 2014 and is based in York, the United Kingdom.
Industry
Biotechnology
IPO Date
2021-12-22
Stock Exchange
LSE
Ticker
APTA.L
According to Aptamer Group plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.80. This represents a change of 87.73% compared to the average of -0.43 of the last 4 quarters.
The mean historical PE Ratio of Aptamer Group plc over the last ten years is -72.87. The current -0.80 PE Ratio has changed 9.78% with respect to the historical average. Over the past ten years (40 quarters), APTA.L's PE Ratio was at its highest in in the June 2023 quarter at -0.22. The PE Ratio was at its lowest in in the September 2018 quarter at -107.20.
Average
-72.87
Median
-38.39
Minimum
-214.41
Maximum
-0.59
Discovering the peaks and valleys of Aptamer Group plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 47.45%
Maximum Annual PE Ratio = -0.59
Minimum Annual Increase = -98.12%
Minimum Annual PE Ratio = -214.41
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.88 | 47.45% |
| 2023 | -0.59 | -98.12% |
| 2022 | -31.66 | -29.83% |
| 2021 | -45.12 | -68.80% |
| 2020 | -144.58 | -32.57% |
The current PE Ratio of Aptamer Group plc (APTA.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.04
5-year avg
-44.57
10-year avg
-72.87
Aptamer Group plc’s PE Ratio is greater than Poolbeg Pharma PLC (-3.24), greater than Arecor Therapeutics plc (-3.45), greater than Sareum Holdings plc (-4.89), less than Novacyt S.A. (-0.67), greater than Fusion Antibodies plc (-8.16), greater than Renalytix Plc (-0.93), greater than Inspiration Healthcare Group plc (-1.15), less than Oxford BioDynamics Plc (-0.18), less than Futura Medical plc (2.30), greater than Genflow Biosciences plc (-3.68),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.24 | N/A | |
| -3.45 | N/A | |
| -4.89 | N/A | |
| -0.67 | N/A | |
| -8.16 | N/A | |
| -0.93 | N/A | |
| -1.15 | N/A | |
| -0.18 | N/A | |
| 2.30 | N/A | |
| -3.68 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptamer Group plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aptamer Group plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Aptamer Group plc's PE Ratio?
How is the PE Ratio calculated for Aptamer Group plc (APTA.L)?
What is the highest PE Ratio for Aptamer Group plc (APTA.L)?
What is the 3-year average PE Ratio for Aptamer Group plc (APTA.L)?
What is the 5-year average PE Ratio for Aptamer Group plc (APTA.L)?
How does the current PE Ratio for Aptamer Group plc (APTA.L) compare to its historical average?